• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Participating Faculty

Publication
Article
Supplements and Featured PublicationsTranslating Clinical Evidence Into Value-Based Payment Models: Pooled Analyses of Innovative Real-World Outcomes Agreements for Ticagrelor in the United States
Volume 26
Issue 13

FACULTY

Durgesh Bhandary, MS, BPharm

Senior Director

HEOR

AstraZeneca

Wilmington, Delaware

Nipun Atreja, PhD, MS

Director

Payor Evidence

Philadelphia, Pennsylvania

Daniel A. Belletti, MA, BSN, RN

Field Health Outcomes Director

AstraZeneca

Wilmington, Delaware

Narinder Bhalla, MD

Executive Director

Cardiovascular and Metabolic Diseases

AstraZeneca

Wilmington, Delaware

Naeem D. Khan, MD

Vice President

Medical Europe and Canada

AstraZeneca

Wilmington, Delaware

David S. Cobden, PhD, MPH, MSc, MBA

Medical Executive Director

National Accounts

Genentech

San Francisco, California

FACULTY DISCLOSURES

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

Durgesh Bhandary, MS, BPharm

EMPLOYMENT

AstraZeneca

MEETING/CONFERENCE ATTENDANCE

AHA, AMCP

STOCK OWNERSHIP

AstraZeneca

Nipun Atreja, PhD, MS

EMPLOYMENT

AstraZeneca

STOCK OWNERSHIP

AstraZeneca

Daniel A. Belletti, MA, BSN, RN

EMPLOYMENT

AstraZeneca

STOCK OWNERSHIP

AstraZeneca

Narinder Bhalla, MD

EMPLOYMENT

AstraZeneca

STOCK OWNERSHIP

AstraZeneca

Naeem D. Khan, MD

EMPLOYMENT

AstaZeneca

STOCK OWNERSHIP

AstraZeneca

David S. Cobden, PhD, MPH, MSc, MBA

EMPLOYMENT

AstraZeneca

STOCK OWNERSHIP

AstraZeneca

© 2024 MJH Life Sciences
AJMC®
All rights reserved.